The U.S. Air Force Defense Finance and Accounting Service (DFAS) awarded a $943,110 Firm Fixed Price contract to the Foundation For Advancing Veterans Health Research, a non-profit organization, for research and development services. The contract is for a randomized clinical trial evaluating the effectiveness of quetiapine in reducing polypharmacy among patients with post-concussive syndrome in San Antonio, Texas. The Foundation For Advancing Veterans Health Research also provides staffing, biostatistics, bioinformatics, and research support for other clinical trials, including a study on responses to aeroallergen challenges before and after receipt of the drug dupilumab. This contract is not set-aside and has a completion date of December 22, 2025.
Generated 12/26/24, 9:28 AM